Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 2 Apr 24 EFFECT Notice of effectiveness
- 1 Apr 24 424B3 Prospectus supplement
-
25 Mar 24 S-3 Shelf registration
OTLK similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated December 22, 2023, with respect to the consolidated financial statements of Outlook Therapeutics, Inc., incorporated herein by reference, and to the reference to our firm under the heading "Experts" in the prospectus.
/s/ KPMG LLP | |
Philadelphia, Pennsylvania | |
March 25, 2024 |